Immunotherapy vs Best Supportive Care for Patients With Hepatocellular Cancer With Child-Pugh B Dysfunction
Claudia Angela Maria Fulgenzi(Università Campus Bio-Medico), Calogero Cammà(Department of Health), Rohini Sharma(Hammersmith Hospital), Joong‐Won Park(National Cancer Center), Tiziana Pressiani(IRCCS Humanitas Research Hospital), Amit G. Singal(Southwestern Medical Center), Celina Ang(Icahn School of Medicine at Mount Sinai), Pei‐Chang Lee(National Yang Ming Chiao Tung University), Francesca Salani(Scuola Superiore Sant'Anna), Antonella Cammarota(Humanitas University), Kornelius Schulze(Universität Hamburg), Aman Mehan(Hammersmith Hospital), Antonio D’Alessio(Hammersmith Hospital), Ciro Celsa(Department of Health), Federica Lo Prinzi(Campus Bio Medico University Hospital), Alessandro Parisi(Marche Polytechnic University), Johann von Felden(Universität Hamburg), Naoshi Nishida(Kindai University Hospital), Masatoshi Kudo(Kindai University), Caterina Vivaldi(Scuola Superiore Sant'Anna), Paul El Tomb(University of Oklahoma Medical Center), Giorgia Ghittoni(Ospedale di Belcolle), Susanna V. Ulahannan(Oklahoma State University Oklahoma City), Bernhard Scheiner(Medical University of Vienna), Anwaar Saeed(University of Pittsburgh), Samuel Phen(The University of Texas Southwestern Medical Center), Anjana Pillai(University of Chicago), Robert Thimme(University of Freiburg), Matthias Pinter(Medical University of Vienna), Thomas U. Marron(Icahn School of Medicine at Mount Sinai), Gianluca Masi(University of Pisa), Linda Y. Wu(Columbia University Irving Medical Center), Lorenza Rimassa(Humanitas University), Giulia Francesca Manfredi(Università degli Studi del Piemonte Orientale “Amedeo Avogadro”), Dominik Bettinger(University of Freiburg), Hong Jae Chon(CHA University Bundang Medical Center), Peter R. Galle(Johannes Gutenberg University Mainz), Yi‐Hsiang Huang(First Hospital of Lanzhou University), Martin Schönlein(Universität Hamburg), Mario Pirisi(Università degli Studi del Piemonte Orientale “Amedeo Avogadro”), Bruno Vincenzi(Campus Bio Medico University Hospital), Arndt Vogel(Princess Margaret Cancer Centre), Anuhya Gampa(University of Chicago), Marianna Silletta(Università Campus Bio-Medico), Wei-Fan Hsu(China Medical University), Emanuela Di Giacomo(Campus Bio Medico University Hospital), Brooke Wietharn(The University of Kansas Cancer Center), Andrea Napolitano(National Health Service), Henning Wege(Universität Hamburg), Jaekyung Cheon(CHA University Bundang Medical Center)
Cited by 37
Related Papers
An inflammatory cytokine signature predicts COVID-19 severity and survival
|Nature Medicine|2020|2.7k
Simplified criteria for the diagnosis of autoimmune hepatitis†
|Hepatology|2008|1.9k
AASLD Practice Guidance on prevention, diagnosis, and treatment of hepatocellular carcinoma
|Hepatology|2023|1.6k
Tremelimumab plus Durvalumab in Unresectable Hepatocellular Carcinoma
|NEJM Evidence|2022|1.4k
Gastric cancer: ESMO Clinical Practice Guideline for diagnosis, treatment and follow-up
|Annals of Oncology|2022|1.4k